SynergEyes and the Brien Holden Vision Institute (BHVI) have partnered to produce new contact lens solutions for myopic and presbyopic patients.
An exclusive worldwide licensing agreement has been signed that will enable BHVI’s technologies to be delivered via SynergEyes’ hybrid contact lenses.
The companies explained that the contact lens will enable eye care professionals to offer customisable vision correction to meet the needs of individual patients.
President and CEO of SynergEyes, James Kirchner, said: “Working with a recognised worldwide leader like the BHVI, we plan to bring an extended depth of focus lens design onto the hybrid platform to the global market.”
The BHVI’s extended depth of focus designs provide a series of smooth, non-monotonic power variations across the optic zone to deliberately manipulate multiple higher-order aberrations. The BHVI explained that this facilitates a balanced visual performance designed to satisfy presbyopes with low, medium and high-add requirements.
Chief executive officer at the BHVI, Professor Kevin Naidoo, said: “We are delighted to be partnering with SynergEyes to bring our novel extended depth of focus designs in myopia and presbyopia management in specialty hybrid contact lenses and make them available to a broader market around the world.”
He highlighted that it is especially important for managing myopia and addressing a “looming public health crises” as the BHVI aims to slow the progression of myopia in children and reduce the risk of permanent vision impairment.